Inhibition of PA28γ expression can alleviate osteoarthritis by inhibiting endoplasmic reticulum stress and promoting

Haokun Mo1, Kai Sun1, Yanjun Hou1

  • 1Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Bone & Joint Research
|November 20, 2024
PubMed
Abstract

Insights

PA28γ knockdown in chondrocytes reduces osteoarthritis progression by inhibiting inflammation, apoptosis, and endoplasmic reticulum stress. This approach also promotes STAT3 phosphorylation, offering a potential therapeutic strategy for osteoarthritis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Orthopedics

Background:

  • Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by cartilage breakdown.
  • PA28γ, a proteasome activator, influences cellular processes like apoptosis and inflammation, suggesting a role in OA pathogenesis.

Purpose of the Study:

  • To investigate the role of PA28γ in osteoarthritis development and its underlying mechanisms.
  • To explore the impact of PA28γ on chondrocyte endoplasmic reticulum (ER) stress and associated signaling pathways.

Main Methods:

  • Primary chondrocytes were isolated from mice and treated to assess PA28γ effects on OA indicators.
  • Western blotting, real-time PCR, and immunofluorescence were used to study PA28γ in ER stress.
  • An OA mouse model was created using destabilized medial meniscus (DMM) surgery, with PA28γ expression reduced via adenovirus injection.

Main Results:

  • PA28γ knockdown improved chondrocyte anabolism/catabolism, inhibited inflammation, apoptosis, and ER stress.
  • PA28γ knockdown modulated IRE1α phosphorylation and TRAF2 expression, impacting MAPK and NF-κB pathways.
  • PA28γ knockdown promoted STAT3 phosphorylation, reducing ER stress, while its inhibition exacerbated ER stress. Cartilage destruction was reduced in vivo.

Conclusions:

  • PA28γ knockdown mitigates OA by inhibiting chondrocyte anabolic/catabolic dysregulation, inflammation, and apoptosis.
  • PA28γ knockdown suppresses ER stress in chondrocytes through enhanced STAT3 phosphorylation, presenting a potential therapeutic target for OA.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
5.3K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K